( Reuters) – The report on Tuesday of an effective treatment for the brand-new coronavirus brought uncertainty together with optimism amongst U.S. doctors, who said the recent withdrawal of a prominent COVID-19 study left them wishing to see more data.
A pharmacist displays a box of Dexamethasone at the Erasme Hospital amid the coronavirus illness (COVID-19) outbreak, in Brussels, Belgium, June 16,2020 REUTERS/Yves Herman
Global pressure to discover a cure or vaccine has sped up the procedure of reporting coronavirus research study results, feeding confusion over whether therapies have actually been shown reliable. One prominent COVID research study was withdrawn this month by highly regarded British medical journal The Lancet over data issues.
Trial results announced on Tues